Holen Sie sich die Stockscreener-App
22.82
8.36%
1.76
Handel nachbörslich:
22.82
Schlusskurs vom Vortag:
$21.06
Offen:
$21.5
24-Stunden-Volumen:
195.81K
Relative Volume:
0.57
Marktkapitalisierung:
$1.34B
Einnahmen:
$83.72M
Nettoeinkommen (Verlust:
$-143.89M
KGV:
-8.1129
EPS:
-2.8128
Netto-Cashflow:
$-120.48M
1W Leistung:
-1.81%
1M Leistung:
-13.66%
6M Leistung:
-11.76%
1J Leistung:
+37.89%
1-Tages-Spanne:
$21.50
$23.05
1-Wochen-Bereich:
$20.40
$23.13
52-Wochen-Spanne:
$14.10
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
22.82 | 1.23B | 83.72M | -143.89M | -120.48M | -2.8128 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | BTIG Research | Buy |
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
KMTS|Kestra Medical Technologies Ltd|Price:21.850|Chg%:+0.790 - TradingKey
Kestra Medical Technologies (KMTS) Secures $200 Million Debt Facility Without New Equity - simplywall.st
KMTS|Kestra Medical Technologies Ltd|Price:21.060|Chg%:-0.510 - TradingKey
TradingKey - TradingKey
Kestra Medical Technologies Ltd - TradingKey
Kestra Medical Technologies Ltd (KMTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kestra Medical's Bullish Fundamentals Driven by Large Total Addressable Market, Sustained Share Gains, Oppenheimer Says - marketscreener.com
Oppenheimer initiates Kestra Medical stock rating at Perform By Investing.com - Investing.com South Africa
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Oppenheimer - MarketBeat
Oppenheimer Initiates Kestra Medical at Market Perform - Moomoo
Goodwin Guides IP For Pharmakon On Up To $200 Million Financing For Kestra Medical Technologies - Mondaq
Kestra Medical Technologies (KMTS) Investor Outlook: Exploring a 29% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. Common Stock (NASDAQ: KMTS) Stock Price, News & Analysis - Kalkine
Kestra Medical Technologies, Ltd. (KMTS) reports Q4 loss, tops revenue estimates - MSN
Kestra Medical Technologies Insider Sold Shares Worth $336,609, According to a Recent SEC Filing - Moomoo
Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell - MarketBeat
Form 4 Kestra Medical Technologies Inc For: 17 July By Investing.com - Investing.com Nigeria
Kestra Medical Technologies CEO Webster sells $336,609 in stock - Investing.com UK
Kestra Medical Technologies CEO Webster sells $336,609 in stock By Investing.com - Investing.com South Africa
Kestra Medical CEO Brian Daniel Webster sells USD 333,745 of common shares - Bitget
Form 4 Kestra Medical Technologies Inc For: 17 July - Investing.com India
Kestra Medical Technologies (KMTS) awards 39,113 shares to its CBO - Stock Titan
Kestra Medical Technologies (KMTS) CCO awarded 58,832 performance-based shares - Stock Titan
Kestra Medical (KMTS) CFO receives 44,118 performance-based shares - Stock Titan
Kestra Medical (KMTS) counsel earns 58,832-share stock award - Stock Titan
Kestra Medical Technologies (KMTS) CEO gets 176,470-share award, sells 15,000 - Stock Titan
A Quick Look at Today's Ratings for Kestra Medical Technologies(KMTS.US), With a Forecast Between $30 to $32 - Moomoo
Analysts Offer Insights on NA Companies: Janus Living, Inc. Class A (JAN) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Kestra Medical Technologies Earnings Call Highlights Rapid Growth - TipRanks
Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land - simplywall.st
Akin, an Elite Global Law Firm - akingump.com
Kestra Medical Technologies Inc Outlook FY Re - Moomoo
Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale - Stock Titan
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Raised to $28.43, Implies 18% Upside - TradingView
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Kestra Medical Technologies secures USD 200M of non-dilutive financing - Medical Buyer
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Cut to $27.5, Implies 14% Upside - TradingView
Kestra Medical Technologies Reports Strong Fiscal 2026 Growth - TipRanks
KMTS SWOT Analysis: Key Insights from 10-K Filing - GuruFocus
Earnings call transcript: Kestra Medical posts strong Q4 2026 sales, misses EPS - Investing.com Canada
Kestra Medical secures $75M loan facility with Pharmakon - Investing.com UK
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript - The Motley Fool
Kestra Medical Technologies Q4 2026 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings - GuruFocus
Kestra FY27 outlook set at $137M as Q4 revenue jumps 66% - scanx.trade
Kestra Medical secures $75M loan facility with Pharmakon By Investing.com - Investing.com South Africa
Kestra Medical Technologies Q4 Earnings Call Highlights - MarketBeat
Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market - Stock Titan
KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) — 10-K Summary - TradingView
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):